feed,title,long_url,short_url
SeekingAlpha,Sarepta cut to neutral at Citi after DMD gene therapy trial failure,https://seekingalpha.com/news/3650607,
SeekingAlpha,Lands' End jumps 4% after setting guidance ahead of consensus marks,https://seekingalpha.com/news/3650606,
